News >

Liquid Biopsy Screening Protocol Aims to Identify Actionable Targets in mCRC

Brandon Scalea
Published: Wednesday, Apr 24, 2019

Kristen Ciombor, MD, MSCI

Kristen Ciombor, MD, MSCI

The rise of precision medicine in the metastatic colorectal cancer (mCRC) paradigm has led to more tailored treatment approaches; moreover, the goal of the ongoing COLOMATE study is to identify actionable targets to improve outcomes, said Kristen Ciombor, MD, MSCI.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication